NCT02527083

Brief Summary

Research suggests that the type of anesthesia used for surgery may affect intraoperative stress hormone levels. There is also data to support that an increased level of stress hormones leads to increased pain after surgery. The primary aim of this study is to determine the effect of anesthesia type on long term pain after hernia surgery. In this study, patients undergoing inguinal hernia repair will be randomized to an anesthetic group, either Total Intravenous Anesthesia (TIVA) maintained with propofol or Balanced Inhaled Anesthesia (BIA) maintained with sevoflurane. This will allow us to look at any differences in short and long-term pain after hernia repair depending on type of anesthesia received.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2015

Longer than P75 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2015

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 18, 2015

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
6.6 years until next milestone

Results Posted

Study results publicly available

December 31, 2025

Completed
Last Updated

December 31, 2025

Status Verified

May 1, 2021

Enrollment Period

4.4 years

First QC Date

January 27, 2015

Results QC Date

May 4, 2021

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Score, Chronic

    Pain as measured by the Intensity Score of the Pain Quality Assessment Scale (PQAS) at each of the time points after surgery. The scale goes from 0 (no pain) to 10 (the most intense pain sensation imaginable). Higher scores mean worse pain.

    1 month, 3 months, 6 months, 12 months

Secondary Outcomes (1)

  • Pain Score, Acute

    1 day

Study Arms (3)

BIA

ACTIVE COMPARATOR

Balanced Inhalational Anesthesia (consisting of a sevoflurane inhaled anesthestic only)

Drug: SevofluraneDrug: Remifentanil

TIVA-K

ACTIVE COMPARATOR

Total intravenous anesthetic with ketamine

Drug: PropofolDrug: Ketamine

TIVA-R

ACTIVE COMPARATOR

Total intravenous anesthetic with remifentanil

Drug: PropofolDrug: Remifentanil

Interventions

Also known as: Ultane
BIA
Also known as: Ultiva
BIATIVA-R
Also known as: Ketalar
TIVA-K
Also known as: Diprivan
TIVA-KTIVA-R

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All male patients undergoing herniorrhaphy surgery that requires general anesthesia.

You may not qualify if:

  • Subjects unable to communicate directly with the investigators, due to being non-English speaking, loss of hearing, or incompetence.
  • A history of malignant hyperthermia, pseudocholinesterase deficiency, or other disease that prevents anesthetic randomization.
  • Pain-related disorders such as fibromyalgia or other chronic pain syndromes.
  • Emergency surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acute PainChronic PainHernia

Interventions

PropofolSevofluraneRemifentanilKetamine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCyclohexanesCycloparaffinsHydrocarbons, Alicyclic

Results Point of Contact

Title
James Ibinson, MD, PhD
Organization
VA Pittsburgh Healthcare System

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2015

First Posted

August 18, 2015

Study Start

January 1, 2015

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

December 31, 2025

Results First Posted

December 31, 2025

Record last verified: 2021-05